These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6349943)

  • 21. Desoximetasone--a new topical corticosteroid: short- and long-term experiences.
    Savin RC
    Cutis; 1978 Mar; 21(3):403-7. PubMed ID: 344003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effect of tacrolimus and betamethasone valerate on the passive sustainable hydration of the stratum corneum in atopic dermatitis.
    Xhauflaire-Uhoda E; Thirion L; Piérard-Franchimont C; Piérard GE
    Dermatology; 2007; 214(4):328-32. PubMed ID: 17460405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative effectiveness of fluocinolone acetonide and hydrocortisone ointments in allergic dermatoses].
    Eriksson-Lihr Z
    Suom Laakaril; 1965 Aug; 20(23):1561-8. PubMed ID: 5866197
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of fluocinonide in a double-blind study with betamethasone valerate.
    Binder R; McCleary J
    Curr Ther Res Clin Exp; 1972 Jan; 14(1):35-8. PubMed ID: 4257862
    [No Abstract]   [Full Text] [Related]  

  • 25. Double blind controlled study of treatment of atopic eczema with a preparation of hydrocortisone in a new drug delivery system versus betamethasone 17-valerate.
    Almeyda J; Burt BW
    Br J Dermatol; 1974 Nov; 91(5):579-83. PubMed ID: 4611469
    [No Abstract]   [Full Text] [Related]  

  • 26. A double-blind comparison of fluocinonide and betamethasone valerate ointments.
    McCuistion CH; Schoch EP; Warthan TL
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):44-7. PubMed ID: 4632505
    [No Abstract]   [Full Text] [Related]  

  • 27. [Systemic effects of topical application of beclomethasone dipropionate--comparative studies with betamethasone 17-valerate ointment and fluocinonide cream (author's transl)].
    Nihon Hifuka Gakkai Zasshi; 1979 Feb; 89(2):61-8. PubMed ID: 374799
    [No Abstract]   [Full Text] [Related]  

  • 28. [Systemic effects of topically applied hydrocortisone 17-butyrate 21-propionate ointment--comparative studies with betamethasone 17-valerate and hydrocortisone 17-butyrate ointment (author's transl)].
    Takeda K
    Nihon Hifuka Gakkai Zasshi; 1982 Mar; 92(4):503-13. PubMed ID: 7050471
    [No Abstract]   [Full Text] [Related]  

  • 29. Hydrocortisone 17-butyrate (Locoid) 0.1% fatty cream versus desonide (Apolar) 0.1% ointment in the treatment of patients suffering from atopic dermatitis.
    Rajka G; Verjans HL
    J Int Med Res; 1986; 14(2):85-90. PubMed ID: 3516754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of desonide ointment, 0.05%, on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis.
    Lucky AW; Grote GD; Williams JL; Tuley MR; Czernielewski JM; Dolak TM; Herndon JH; Baker MD
    Cutis; 1997 Mar; 59(3):151-3. PubMed ID: 9071556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Topical treatment of dermatoses with difluocortolone valerate fatty ointment].
    Carvajal Rosado VM
    Z Hautkr; 1976; 51 Suppl 1():27-9. PubMed ID: 795183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of eczematous dermatitis with amcinonide or betamethasone valerate. A double-blind comparative study.
    Rosenberg EW
    Cutis; 1979 Dec; 24(6):642-5. PubMed ID: 391500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrocortisone butyrate 0.1% lotion in the treatment of atopic dermatitis in pediatric subjects.
    Matheson R; Kempers S; Breneman D; Draelos Z; Johnson CE; Loss R; Hogan DJ; Schoenfeld R; Checketts S; Kircik L; Fivenson D; Hebert AA; Williams J; Hamlin R; Groisser D; Piacquadio D
    J Drugs Dermatol; 2008 Mar; 7(3):266-71. PubMed ID: 18380208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hydrocortisone-17-butyrate (0.1 percent) versus hydrocortisone acetate (1 percent) in atopic dermatitis. Controlled double-blind study of 20 children].
    Giannetti A; Laria G; Seidenari S
    Minerva Pediatr; 1981 Jun; 33(12):597-600. PubMed ID: 7022158
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical experiences with hydrocortisone 17-butyrate.
    Yasuda T
    Dermatologica; 1976; 152 Suppl 1():221-9. PubMed ID: 782956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term topical corticosteroid therapy (halcinonide ointment) in the management of atopic dermatitis.
    Lupton ES; Abbrecht MM; Brandon ML
    Cutis; 1982 Nov; 30(5):671-5. PubMed ID: 6756798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of Besnier's prurigo with Calmuril-hydrocortisone 1% cream and triamcinolone acetonide 0,1% cream. A controlled clinical study].
    Ludvigsen KE; Gadborg E
    Ugeskr Laeger; 1975 May; 137(19):1062-4. PubMed ID: 1094657
    [No Abstract]   [Full Text] [Related]  

  • 39. Atopic dermatitis.
    Roane J
    South Med J; 1971 Nov; 64(11):1395-7. PubMed ID: 5126808
    [No Abstract]   [Full Text] [Related]  

  • 40. Multicenter trial for long-term safety and efficacy comparison of 0.05% desonide and 1% hydrocortisone ointments in the treatment of atopic dermatitis in pediatric patients.
    Jorizzo J; Levy M; Lucky A; Shavin J; Goldberg G; Dunlap F; Hinds A; Strelka L; Baker M; Tuley M
    J Am Acad Dermatol; 1995 Jul; 33(1):74-7. PubMed ID: 7601950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.